-
Mashup Score: 0Semaglutide Patient Safety Updates | semaglutide.com - 5 day(s) ago
Get the latest patient safety updates on compounded and counterfeit semaglutide. Learn more about Novo Nordisk medications containing semaglutide.
Source: www.novomedlink.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Semaglutide Patient Safety Updates | semaglutide.com - 6 day(s) ago
Get the latest patient safety updates on compounded and counterfeit semaglutide. Learn more about Novo Nordisk medications containing semaglutide.
Source: www.novomedlink.comCategories: General Medicine News, PayerTweet-
Knockoff GLP-1 medicines pose a threat to patient safety. At @SXSW, our very own Negelle Morris will discuss the rise of misinformation around GLP-1s and the importance of FDA approval for GLP-1s. Learn more about our commitment to patient safety: https://t.co/tChwM9gKSu https://t.co/TIBTmMBO4r
-
-
Mashup Score: 3News details - 10 month(s) ago
News details
Source: www.novonordisk-us.comCategories: General Medicine News, PayerTweet-
Today, we released our Q1 2024 financial results. Read the press release to learn more: https://t.co/ofkBbIxDo3 $NVO #press #earnings
-
-
Mashup Score: 8News details - 1 year(s) ago
News details
Source: www.novonordisk-us.comCategories: General Medicine News, PayerTweet-
Novo Nordisk medicine receives @US_FDA approval for new cardiovascular risk reduction indication: https://t.co/oPwKEFh9wt
-
-
Mashup Score: 2News details - 1 year(s) ago
News details
Source: www.novonordisk-us.comCategories: General Medicine News, PayerTweet-
Today we released our Q4 and FY 2023 financial results. Read the press release: https://t.co/8VdvcSBnLo. $NVO #press #earnings https://t.co/9Lzg0sKcZt
-
-
Mashup Score: 2Diversity, equity, inclusion & belonging - 1 year(s) ago
Novo Nordisk is committed to make diversity & inclusion part of everything we do. Learn about the programs we offer designed to strengthen our culture and care for our communities.
Source: www.novonordisk-us.comCategories: General Medicine News, PayerTweet-
We strive to drive meaningful change for our employees and the patients we serve. Our goal is to embed #Diversity, #Equity, #Inclusion and #Belonging (DEI&B) into our business, embracing differences to achieve our purpose. Read our 2023 DEI&B Report: https://t.co/lnmqiyqo3x. https://t.co/9dGpmwJxr2
-
Knockoff GLP-1 medicines pose a threat to patient safety. At @SXSW, our very own Negelle Morris will discuss the rise of misinformation around GLP-1s and the importance of FDA approval for GLP-1s. Learn more about our commitment to patient safety: https://t.co/tChwM9gKSu https://t.co/TIBTmMBO4r